Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
SOMSA'26 - Synthetic Blood Substitutes In Far-Forward Special Operations
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
Prolonged field care often means holding casualties far from a reliable blood supply. In this episode, recorded with the sponsorship and support of the Special Operations Medical Association, a UK prehospital medic with 16 years of service presents a University College Cork diploma thesis on what to do when whole blood at the point of wounding is running out.
The talk argues that, in a contested large-scale conflict, whole blood at the front is hard to sustain: screening, cold chain, power, and specialist monitoring all add burden, and supply lines can be targeted. The speaker proposes a layered approach with shelf-stable products: dried or spray-dried plasma at the point of wounding, given with TXA and a fluid warmer, then hemoglobin vesicles when the clinician judges it is time, and whole blood as the gold standard once the environment is permissive enough.
He covers the history of dried plasma from World War II to modern lyophilized products, how slow-swirl reconstitution works, the UK Blood Far Forward spray-dried plasma scheme, and why earlier hemoglobin-based oxygen carriers caused problems that later hemoglobin vesicles are designed to avoid. In the questions, a listener asks whether the sterile water you still have to carry just moves the logistics burden around, and others ask about allied programs and the Japan vesicle trials.
Free downloads: www.prolongedfieldcare.org
Top 5 takeaways
- The talk is built on a planning question: what other options are there when whole blood has run out (01:34–02:24)?
- The speaker's proposed sequence is dried plasma at the point of wounding, with TXA and a fluid warmer, then hemoglobin vesicles, then whole blood as the gold standard when the situation is permissive (12:24–14:24). Current TCCC and JTS guidance treat dried plasma as a bridge, not a replacement, and do not include hemoglobin vesicles.
- Dried plasma is a powder reconstituted with sterile water and mixed with a slow swirl, not by shaking (07:14–07:38). The speaker cites a 5–10 minute mix and a two-year shelf life. The JTS Dried Plasma CPG supports a two-year shelf life at 2–25 °C, "do not shake" mixing, and sterile water only; mix times are product-specific.
- You still carry the water. The speaker puts five units at just over a kilogram and argues that is still lighter than blood in a refrigerator or a Golden Hour box, and that shelf-stable stocks can be forward-mounted (15:04–16:27). The 200 mL figure is product-specific.
- The speaker describes hemoglobin vesicles as a second-generation oxygen carrier with a roughly 12-hour half-life, still in clinical trials (10:00–11:00). They are not an approved field product in current TCCC or JTS guidance.
Chapters
00:00 Intro, disclaimer, and SOMA sponsorship
00:33 Speaker intro: UK prehospital medic, UCC diploma, SOMA talk
01:16 The question: what do you do when whole blood runs out
02:38 Why whole blood is hard to sustain at the front
05:05 The argument: shelf-stable products in a contested environment
06:11 Dried plasma: history, mixing, and shelf life
07:41 UK Blood Far Forward, and spray-dried vs freeze-dried
08:32 Hemoglobin vesicles, and why earlier oxygen carriers had problems
10:24 Product comparison and limitations
11:20 A layered timeline from the point of wounding to blood
13:01 Approvals, training, and conclusion
14:28 Questions: water weight, other national programs, Japan trials